Dingwo Bioengineering (Shanghai) Co., Ltd.
Make cell culture easier and solidify the “cornerstone” for China’s biomedicine.
Founded in 2022, Dingwo Bioengineering (Shanghai) Co., Ltd. has its headquarters and R&D center at the Shanghai Zhangjiang National Biomedical Industry Base, along with a modern production base in Zhoupu. As an innovative company focusing on core upstream raw materials for biomedicine, we are committed to building a trustworthy domestic brand for cell culture.
Building on the founding team’s over 20 years of deep experience in the serum industry, Dingwo Bio has established a core technology system that spans from source control to process innovation. The company fully applies automatic serum direct collection instruments, and has pioneered the launch of multiple patented technologies and products, including the second-generation press-to-use ready‑to‑mix culture medium and a serum thawing instrument. We continue to provide high‑value OEM services to many domestic brands.
On the R&D front, Dingwo Bio adheres to a validation-driven quality approach. The company’s R&D center maintains dozens of different cell lines. Before market launch, every product undergoes large-scale, multi-dimensional cell screening and rigorous validation to ensure its stability and suitability in real culture scenarios.
⚙️Full-process quality control system
📊 Large-scale screening and validation
🏭 OEM service experience
